Blockade of D-2 dopamine receptors strongly enhances the potency of enkephalins to inhibit dopamine-sensitive adenylate cyclase in rat neostriatum: involvement of delta- and mu-opioid receptors
Open Access
- 1 August 1986
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 6 (8) , 2235-2239
- https://doi.org/10.1523/jneurosci.06-08-02235.1986
Abstract
The interactions between dopamine receptors and opioid receptors coupled to adenylate cyclase in rat neostriatum were investigated. cAMP efflux from neostriatal slices induced by simultaneous activation of (stimulatory) D-1 and (inhibitory) D-2 dopamine receptors with 30 .mu.M dopamine was inhibited by the preferential .delta.-opioid receptor agonist [D-Ala2-D-Leu5] enkephalin (DADLE) and the .mu.-opioid receptor agonist morphine with an EC50 of 100 and 800 nM, respectively. On selective D-1 receptor activation (i.e., with D-2 receptors blocked by 10 .mu.M (.sbd.)sulpiride), the EC50 of DADLE was strongly reduced to 3 mM, whereas that of morphine was unaffected. When D-1 and D-2 receptors were activated simultaneously, the inhibitory effects of DADLE (0.3 .mu.M) and morphine (3 .mu.M) on cAMP efflux were antagonized equally well by naloxone, a .mu.-opioid receptor antagonist. In contrast, on selective D-1 reception activation, naloxone was about 20 times more potent in antagonizing the inhibitory effect of morphine than DADLE. Moreover, the .delta.-opioid receptor antagonist ICI 174864 (0.75 .mu.M) did not affect the inhibitory effect of morphine but antagonized that of DADLE, provided that D-2 receptors were blocked. The highly selective .delta.-opioid receptor agonist [D-Pen2-D-Pen5] enkephalin (DPDPE) inhibited dopamine-stimulated cAMP efflux only when D-2 receptors were blocked. Similar results were obtained when the agonists SKF 38393 and LY 141865 were used to activate D-1 and D-2 receptors, respectively. These data indicate that blockade of D-2 receptors in the neostriatum elicits the coupling of .delta.-opioid receptors to dopamine-sensitive adenylate cyclase, thereby making it considerably more sensitive to inhibition by the enkephalins.This publication has 3 references indexed in Scilit:
- SPECTRUM OF THE μ‐, δ‐ AND κ‐BINDING SITES IN HOMOGENATES OF RAT BRAINBritish Journal of Pharmacology, 1982
- Novel opiate binding sites selective for benzomorphan drugs.Proceedings of the National Academy of Sciences, 1981
- Multiple receptors for dopamineNature, 1979